Jackson Financial Inc. (JXN): what the price assumes

In the published model solve dated 2026-Q2, anchored at $121.16, Jackson Financial Inc. (JXN) is priced for -1.4% earnings growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/JXN

Headline

FieldValue
TickerJXN
CompanyJackson Financial Inc.
Current price$121.16/sh
CompositionRetail Annuities 75% / Institutional Products 7% / Closed Life and Annuity Blocks 17%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Implied earnings growth-1.4%
Price-to-earnings9.4x
Earnings yield10.7%

Uses a multi-year earnings base; the latest year was lumpy (carry / trading / one-offs).

Solve inputs: computed at a 12.9% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base; each 1pp of cost of equity moves the implied earnings growth ~2.6pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.47σ
cohort percentile (of 51 peers)6
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.94x2justifies
Earnings0
Relative1.21x1expensive
Growth0.69x3justifies

Families that justify the price: Asset, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.7%); the inversion above states its own rate.

Per-Model Detail (n=6)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)no
Relative ValuationRelative$100.401.21xyesP/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus
Simple DDMGrowth$26.764.53xyesDPS $3.67, g=-3.9% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-45.33noStage 1: -200% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$136.160.89xyesBook value floor: BV/sh $136.16, ROE negative
Two-Stage Excess ReturnAsset$122.540.99xyesBook value with convergence: BV/sh $136.16, ROE converges to ke
Discounted Future Market CapGrowth$175.800.69xyesRev $5.8B, growth 30% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.4x / 1.7x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$323.540.37xyesMargin ramp: -6% → 10% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$3.5b
Interest coverage-5.0x
Share count CAGR (buyback)-6.2%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Bullet Takeaways

Bull Case

One number frames the entire bull case: the earnings yield. Jackson trades at roughly eight times operating earnings, an earnings yield above 12%, which for a company generating real distributable cash means the stock is priced to return a large fraction of its market value to shareholders every year. It is doing exactly that. The company returned $257 million to common shareholders in the first quarter through $192 million of buybacks and $65 million of dividends, and reiterated a full-year capital-return target of $900 million to $1.1 billion. At that pace the share count has been falling about 6% a year, which means even flat operating earnings translate into rising earnings per share. When a company yields this much and retires this many shares, the math compounds quickly in the owner's favor.

The capital that funds those returns rests on a strong statutory position. The 10-K states the insurance subsidiaries hold "statutory surplus above the level needed to meet current regulatory requirements", the regulatory buffer that determines how much cash can be dividended up to the holding company and out to shareholders. That surplus is the engine behind the buyback, and it is the reason management can commit to a return target rather than hope for one.

The sales engine is also healthier and better diversified than the variable-annuity reputation suggests. Retail annuity sales rose 31% to $5.3 billion, but the growth came from the products that carry less market risk: registered index-linked annuity sales jumped 68% to $2.0 billion and fixed index annuity sales spiked 335% to $756 million, while traditional variable annuities declined. Adjusted operating earnings were $361 million, or $5.15 per share, helped by higher spread income and the lower share count. A business shifting its new sales toward lower-risk guarantees while returning double-digit yields is improving its quality and rewarding holders at the same time.

Bear Case

Start with what a reader sees before any ratio: this is a company that just reported a large loss. Jackson posted a net loss attributable to common shareholders of $435 million, or $6.24 per diluted share, in the first quarter. The loss is not an operating collapse; it comes from the accounting for hedges and the guarantees embedded in its annuities, which reprice with markets. But that is precisely the discomfort: the reported bottom line of this business is not a clean read on how it is doing, and the GAAP number can be deeply negative in a quarter the company describes as operationally fine. An investor has to trust the adjusted figure over the reported one, which is a leap of faith the more skeptical reader is right to resist.

The reason for the volatility is structural and disclosed. The company writes guaranteed benefits inside its products, and its filing states it is "exposed to equity market risk through the guaranteed benefits sold within our" products, with hedging that can be less effective than expected when markets are volatile. That means a sharp equity selloff hits Jackson twice: it raises the value of the guarantees it owes and can strain the hedges meant to offset them. The 10-K also warns that under "stressed or stagnant capital market conditions and with the aging of existing insurance liabilities", the company may need to hold additional statutory reserves, which is the mechanism by which a bad market directly squeezes the surplus that funds the buyback. The capital-return story and the equity-market risk are the same coin.

That is why the cheap multiple is cheap. At eight times earnings the price implies the market expects Jackson's earnings power to decline modestly over time, not grow, and the valuation methods support the price rather than scream value, sitting roughly in line with what asset-based and peer-multiple frames justify. The low multiple is the market's compensation for accepting tail risk it cannot easily model: a business whose reported earnings can lurch into a nine-figure loss on market moves, whose distributable capital depends on a statutory surplus that the same market moves can erode. The yield is high because the risk is real, not because the market has missed something.

Valuation

An annuity issuer like this is best valued on the earnings it can distribute, not its book value, so the lens is the earnings yield. At about eight times earnings, an earnings yield north of 12%, the price embeds a modest decline in earning power over time rather than growth. That is a value setup, and the methods agree: asset-based, relative-multiple, and growth-DCF approaches land at or above the price, so this reads as a value and asset-supported name rather than a stretched one.

The complication, and the reason the multiple stays low, is that the earnings being capitalized are noisy. GAAP results swing with equity markets and hedge accounting, as the first-quarter loss showed, while the operating earnings that the valuation effectively rests on are steadier. A reader should treat the eight-times multiple as the market pricing both the distributable cash and the uncertainty around how much of it survives a stressed market. The price is not betting on growth; it is betting that the capital-return machine keeps running roughly as it has.

Solvency here is a different question than for an operating company. The relevant measure is statutory capital and the surplus available to fund dividends and buybacks, which the company reports as above regulatory requirements, and the holding company carries more cash than debt. The genuine risk is not insolvency in a normal environment; it is that a severe or prolonged market decline forces additional reserves, compresses the surplus, and slows the capital return that is the entire reason to own the stock. The valuation is reasonable on current earnings; the variable is how durable those earnings and that surplus prove through a real market stress.

Catalysts

The first-quarter print was a study in the gap between reported and operating results. Jackson posted a GAAP net loss of $435 million, or $6.24 per diluted share, on less favorable hedging and market-risk-benefit results, while adjusted operating earnings were $361 million, or $5.15 per diluted share. The market reacted to the revenue miss and the headline loss even as the operating and sales metrics were strong, and the shares slid on the report.

The operating momentum is in the product mix and the capital return. Retail annuity sales rose 31% to $5.3 billion, led by a 68% increase in registered index-linked annuity sales to $2.0 billion and a 335% jump in fixed index annuity sales to $756 million, while traditional variable annuity sales declined 6%. The company returned $257 million to shareholders in the quarter and reaffirmed a $900 million to $1.1 billion full-year capital-return target. The signals to watch are whether the shift toward index-linked products continues to lower the book's market sensitivity and whether the capital-return pace holds, since that buyback cadence is the clearest driver of per-share value from here.

Peer Cohorts (Per Segment, With Filing Citations)

Retail Annuities (reported)

Institutional Products (reported)

Closed Life and Annuity Blocks (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings guidance · Q1 2026 earnings release

View the full interactive JXN report on boothcheck